MetLife Investment Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $10.3M | Sell |
117,687
-761
| -0.6% | -$66.4K | 0.06% | 307 |
|
2025
Q1 | $8.09M | Sell |
118,448
-2,119
| -2% | -$145K | 0.04% | 410 |
|
2024
Q4 | $9.38M | Sell |
120,567
-1,844
| -2% | -$143K | 0.05% | 278 |
|
2024
Q3 | $8.21M | Sell |
122,411
-1,967
| -2% | -$132K | 0.05% | 310 |
|
2024
Q2 | $14.1M | Buy |
124,378
+18,102
| +17% | +$2.05M | 0.08% | 174 |
|
2024
Q1 | $14.7M | Sell |
106,276
-3,456
| -3% | -$479K | 0.1% | 160 |
|
2023
Q4 | $13.6M | Sell |
109,732
-2,291
| -2% | -$284K | 0.1% | 161 |
|
2023
Q3 | $10.5M | Sell |
112,023
-2,454
| -2% | -$229K | 0.08% | 193 |
|
2023
Q2 | $14.7M | Sell |
114,477
-597
| -0.5% | -$76.7K | 0.11% | 143 |
|
2023
Q1 | $13.4M | Sell |
115,074
-1,120
| -1% | -$130K | 0.1% | 156 |
|
2022
Q4 | $13.2M | Sell |
116,194
-4,238
| -4% | -$480K | 0.1% | 157 |
|
2022
Q3 | $9.7M | Sell |
120,432
-1,321
| -1% | -$106K | 0.08% | 202 |
|
2022
Q2 | $9.07M | Sell |
121,753
-939
| -0.8% | -$70K | 0.07% | 221 |
|
2022
Q1 | $15.7M | Buy |
122,692
+37,032
| +43% | +$4.74M | 0.1% | 156 |
|
2021
Q4 | $11.5M | Sell |
85,660
-1,752
| -2% | -$235K | 0.09% | 167 |
|
2021
Q3 | $12M | Sell |
87,412
-2,272
| -3% | -$311K | 0.11% | 151 |
|
2021
Q2 | $9.57M | Sell |
89,684
-1,992
| -2% | -$213K | 0.08% | 195 |
|
2021
Q1 | $8.24M | Sell |
91,676
-1,608
| -2% | -$144K | 0.08% | 229 |
|
2020
Q4 | $8.62M | Sell |
93,284
-3,816
| -4% | -$353K | 0.08% | 197 |
|
2020
Q3 | $10M | Buy |
97,100
+536
| +0.6% | +$55.2K | 0.11% | 159 |
|
2020
Q2 | $9.79M | Buy |
+96,564
| New | +$9.79M | 0.11% | 160 |
|
2019
Q2 | – | Sell |
-480
| Closed | -$14.3K | – | 2472 |
|
2019
Q1 | $14.3K | Buy |
480
+4
| +0.8% | +$119 | ﹤0.01% | 2359 |
|
2018
Q4 | $14.3K | Sell |
476
-4
| -0.8% | -$120 | ﹤0.01% | 2353 |
|
2018
Q3 | $17.2K | Buy |
+480
| New | +$17.2K | ﹤0.01% | 2395 |
|